October 12, 2016Circulation
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
Key result
This review evaluates the role of low-dose aspirin for primary cardiovascular prevention in patients with diabetes mellitus, providing a practical risk-based algorithm for initiation in daily practice.
Why the study?
Does low-dose aspirin prevent atherothrombotic events in patients with diabetes mellitus without overt cardiovascular disease?
Population
Patients with diabetes mellitus and no overt cardiovascular disease (primary prevention)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Risk-stratified aspirin decisions in diabetic primary prevention warrant caution; leaves open need for contemporary RCTs.
Structured PICO
Does low-dose aspirin prevent atherothrombotic events in patients with diabetes mellitus without overt cardiovascular disease?
P
Population
Patients with diabetes mellitus and no overt cardiovascular disease (primary prevention)
I
Intervention
Low-dose aspirin
This review evaluates the literature on low-dose aspirin for primary cardiovascular prevention in patients with diabetes mellitus, proposing a practical risk-based algorithm for clinical practice.
Cite This Study
Capodanno et al. (2016) conducted a review in Diabetes Mellitus. Aspirin was evaluated. This review evaluates the role of low-dose aspirin for primary cardiovascular prevention in patients with diabetes mellitus, providing a practical risk-based algorithm for initiation in daily practice.